Back to Search Start Over

Intravenous immunoglobulin: Revisited – My experience

Authors :
Sanjeev S Vaishampayan
Surendra Singh Bhati
Radha R Lachhiramani
Shivank Shrivastava
Prateek Jain
Ajay Singh Raghuwanshi
Source :
Indian Journal of Dermatology, Vol 66, Iss 3, Pp 329-329 (2021)
Publication Year :
2021
Publisher :
Wolters Kluwer Medknow Publications, 2021.

Abstract

Background: Many a times while treating dermatoses conventional therapies are either contraindicated or not effective. Intravenous immunoglobulin (IVIG) is a good alternative available to tide over crises. Method: Over the last 15 years of my practice I have used IVIg in various severe or recalcitrant diseases (including TEN, autoimmune blistering disease,connective tissue disorders , chronic urticaria etc) which were either unresponsive to conventional modality of therapy or primary therapy could not be given because of co-morbidities. Result: IVIg a sterile, highly purified preparation containing more than 95% unmodified IgG,was first approved by FDA in 1981 for 6 diseases. As mentioned above in many circumstances we reached a situation when either conventional primary therapy was contraindicated or patients were not responding. IVIg came to our rescue in large number of conditions to tide over the crisis and also created the environment leading to conventional therapy becoming effective. Very few minor side effects like low grade fever and myalgia were observed in very few cases. No serious or severe side effects were seen, however , one has to be prepared for anaphylactic reaction which is a theoretical possibility. Conclusion: It can be said that IVIg though not a magic drug, is a very effective tool available in the armamentarium of Dermatologists to treat plethora of chronic and intractable dermatoses.

Details

Language :
English
ISSN :
00195154 and 19983611
Volume :
66
Issue :
3
Database :
Directory of Open Access Journals
Journal :
Indian Journal of Dermatology
Publication Type :
Academic Journal
Accession number :
edsdoj.0f998be68f34d90a8c155357630c24b
Document Type :
article
Full Text :
https://doi.org/10.4103/ijd.IJD_559_17